anemia (phenotype): ['A reduction in the number of circulating erythrocytes or in the quantity of hemoglobin.']
Anaemia in chronic diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
D3_ANAEMIAINCHRONICDISEASE
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
838 |
4. Check minimum number of eventsNone |
838 |
5. Include endpointsNone |
838 |
6. Filter based on genotype QC (FinnGen only) |
838 |
Control definitions (FinnGen only)
- Control exclude
- D3_APLASTICANDOTHANAEMIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Anaemia in chronic diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Aplastic and other anaemias
- Anaemias
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5226 | 2347 | 2830 |
| Only index persons | 4405 | 1950 | 2455 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | 0.08 |
| Only index persons | 0.08 | 0.07 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 73.92 | 74.67 | 73.28 |
| Only index persons | 73.78 | 74.70 | 73.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 838 | 312 | 526 |
| Unadjusted period prevalence (%) | 0.19 | 0.11 | 0.23 |
| Median age at first event (years) | 69.37 | 66.54 | 71.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 749
- Matched controls
- 7489
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
187.4
323.0
425
52
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
82.0
297.1
327
70
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
33.2
290.3
403
254
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
+∞
276.7
248
*
B03XA02
ATC
darbepoetin alfa; parenteral
103.9
264.1
281
43
D64.9
ICD-10 Finland
Anaemia, unspecified
43.7
245.0
307
117
N18.8
ICD-10 Finland
Other chronic renal failure
48.4
238.3
291
97
TK800
NOMESCO Finland
Hemodialysis
67.6
216.8
247
54
A11CC03
ATC
alfacalcidol; systemic
54.4
212.2
252
69
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
345.0
188.3
183
7
C03CA01
ATC
furosemide; systemic
10.7
185.5
562
1645
Z49.1
ICD-10 Finland
Extracorporeal dialysis
79.7
183.6
204
35
N18.0
ICD-10 Finland
End-stage renal disease
78.8
166.0
185
31
A12AA04
ATC
calcium carbonate; oral
54.6
154.3
183
44
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
84.2
153.9
170
26
D638, N189
ICD-10 Finland
NA
+∞
150.2
139
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
77.9
143.1
160
26
Z49.0
ICD-10 Finland
Preparatory care for dialysis
97.5
137.3
149
19
V03AE01
ATC
polystyrene sulfonate; oral
84.2
134.7
149
22
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
132.1
133.4
140
13
WW500
NOMESCO Finland
Blood transfusion
24.7
127.6
185
98
Z94.0
ICD-10 Finland
Kidney transplant status
68.8
127.2
145
26
D638, N188
ICD-10 Finland
NA
+∞
122.3
114
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
8.6
112.7
281
486
L04AA06
ATC
mycophenolic acid; systemic
49.6
111.8
135
33
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
187.7
109.6
112
7
127
Kela drug reimbursment
Transplant complication
44.6
107.8
133
36
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.1
105.9
208
231
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
102.2
104.4
113
13
Z49.2
ICD-10 Finland
Other dialysis
148.9
98.8
103
8
137
Kela drug reimbursment
Uraemia requiring dialysis
81.1
94.2
105
15
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
82.1
89.9
100
14
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.3
88.7
245
470
B05DA
ATC
Isotonic solutions
116.3
86.1
92
9
ZX120
NOMESCO Finland
Intravenous
8.0
84.9
215
360
V03AE02
ATC
sevelamer; oral
163.7
84.0
87
6
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
142.2
84.0
88
7
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
155.2
79.8
83
6
D638, N180
ICD-10 Finland
NA
+∞
77.5
73
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
29.3
76.4
104
41
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
45.9
76.0
93
23
C08CA01
ATC
amlodipine; oral
4.2
75.5
459
2033
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
33.0
74.3
98
34
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
74.2
70
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
8.5
73.0
173
255
B05DB
ATC
Hypertonic solutions
107.1
71.4
77
8
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
46.1
70.3
86
21
TPX10
NOMESCO Finland
Implantation of vascular injection port
17.3
70.3
114
77
205
Kela drug reimbursment
Chronic hypertension
4.1
69.5
405
1680
M04AA01
ATC
allopurinol; systemic
5.3
69.2
250
645
N19
ICD-10 Finland
Unspecified kidney failure
12.4
68.2
128
122
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
67.9
375
1472
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
58.7
67.5
79
15
TK820
NOMESCO Finland
Peritoneal dialysis
189.6
67.2
69
*
196
Kela drug reimbursment
Paricalcitol and cinacalcet
96.4
64.1
70
8
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
64.0
477
2379
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.7
62.5
157
249
JN3AD
NOMESCO Finland
Abdominal CT examination
7.6
62.5
158
253
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.0
62.5
344
1319
TPH04
NOMESCO Finland
Cathetrisation of vein
4.3
62.3
291
961
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.9
62.2
171
309
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
70.0
61.5
70
11
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
171.6
60.9
63
*
SPAT1262
SPAT
Handing over of treatment supplies
4.4
59.7
266
833
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
57.9
247
738
B03XA01
ATC
erythropoietin; parenteral
48.1
57.8
70
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.0
57.0
294
1046
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
60.1
56.7
66
12
TK810
NOMESCO Finland
Hemofiltration
58.1
54.7
64
12
N17.9
ICD-10 Finland
Acute renal failure, unspecified
9.8
54.6
116
138
A10AE04
ATC
insulin glargine; parenteral
5.8
53.4
168
356
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
49.9
53.3
64
14
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
5.7
53.0
169
364
L04AD01
ATC
ciclosporin; systemic
20.6
51.8
78
42
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
189.8
51.6
53
*
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.3
51.2
132
214
N02AA05
ATC
oxycodone; systemic
4.3
50.7
221
662
D64.8
ICD-10 Finland
Other specified anaemias
31.8
50.6
67
23
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
10.2
50.1
103
115
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
6.0
50.0
150
298
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
28.6
50.0
68
26
I50.9
ICD-10 Finland
Heart failure, unspecified
4.1
48.6
228
727
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
95.0
48.5
53
6
A10AE05
ATC
insulin detemir; parenteral
7.8
48.3
118
176
H05BX01
ATC
cinacalcet; oral
48.2
48.0
58
13
U14
ICPC
Kidney symptom/complaint
20.0
46.8
71
39
B01AB10
ATC
tinzaparin; parenteral
7.1
46.6
122
201
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
8.4
46.6
108
148
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
53.8
46.5
55
11
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
107.0
46.4
50
5
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
7.1
45.9
120
197
H3603, E103
ICD-10 Finland
NA
32.5
45.6
60
20
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
9.4
45.6
98
118
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
26.9
44.9
62
25
H02AB04
ATC
methylprednisolone; systemic
4.2
44.9
198
591
103
Kela drug reimbursment
Diabetes, insulin-treated
3.2
44.2
319
1412
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
10.4
43.9
89
96
A41.9
ICD-10 Finland
Sepsis, unspecified
10.0
43.0
89
100
321
Kela drug reimbursment
Paricalcitol and cinacalcet
38.7
42.8
54
15
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
15.3
42.3
71
51
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.2
41.6
279
1160
C02AC05
ATC
moxonidine; oral
7.2
40.9
104
163
T89
ICPC
Diabetes insulin dependent
9.9
40.9
85
96
A02BC02
ATC
pantoprazole; systemic
3.0
40.7
550
3595
N25.0
ICD-10 Finland
Renal osteodystrophy
68.2
39.5
45
7
J01MA12
ATC
levofloxacin; systemic
3.4
38.8
231
869
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.9
38.6
182
568
XW000
NOMESCO Finland
Bone marrow biopsy
8.4
38.5
88
117
R50.9
ICD-10 Finland
Fever, unspecified
3.9
38.4
181
565
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.4
37.9
105
185
C07AG02
ATC
carvedilol; oral
5.5
37.5
120
253
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.8
37.2
135
327
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
6.2
37.1
106
194
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
10.4
36.9
74
78
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.0
36.7
95
152
3025
Kela drug reimbursment
Calcium carbonate
72.1
36.3
41
6
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
102.7
36.1
39
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.5
35.6
71
74
I10
ICD-10 Finland
Essential (primary) hypertension
2.7
34.6
538
3622
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
94.5
33.0
36
*
V03AE03
ATC
lanthanum carbonate; oral
177.8
33.0
34
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
32.8
203
774
J01MA02
ATC
ciprofloxacin; systemic
2.6
32.8
372
2072
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.8
32.3
77
109
JN4AD
NOMESCO Finland
Body CT examination
4.6
32.3
122
306
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.5
32.1
87
148
C09AA02
ATC
enalapril; systemic
2.9
31.6
243
1068
UJF32
NOMESCO Finland
Coloscopy
2.8
31.3
262
1214
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
9.1
31.1
67
80
C07AB07
ATC
bisoprolol; oral
2.5
31.1
451
2836
A10AA01
ATC
NA
9.9
30.7
63
69
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
28.8
30.5
41
15
J01FF01
ATC
clindamycin; systemic
2.7
30.5
262
1228
R4110
NOMESCO Finland
Physiotherapy
2.7
30.0
269
1293
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
22.7
29.9
43
20
ZXD05
NOMESCO Finland
Urgent procedure
2.6
29.8
298
1524
A10AA02
ATC
NA
7.3
29.5
73
109
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
7.6
29.4
71
102
XCK10
NOMESCO Finland
Photography of fundus of eye
3.6
29.4
146
467
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
29.2
264
1271
CKC12
NOMESCO Finland
Photocoagulation of retina
6.4
29.2
80
138
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.7
29.1
253
1190
WX202
NOMESCO Finland
Supraclavicular plexus blockade
13.7
28.8
50
39
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
11.6
28.7
54
50
E87.5
ICD-10 Finland
Hyperkalaemia
11.6
28.7
54
50
M10.3
ICD-10 Finland
Gout due to impairment of renal function
50.7
28.6
34
7
N02AX02
ATC
tramadol; systemic, rectal
2.4
28.5
373
2184
L04AX01
ATC
azathioprine; systemic
6.6
28.2
75
124
A46
ICD-10 Finland
Erysipelas
3.2
28.2
167
609
H3601, E103
ICD-10 Finland
NA
23.4
28.1
40
18
306
Kela drug reimbursment
Erythropoietin and darbepoetin
150.6
27.8
29
*
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
26.6
27.7
38
15
3AC01
NOMESCO Finland
NA
20.6
27.7
41
21
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
36.6
27.6
35
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.5
27.4
296
1561
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
27.3
264
1309
I50.0
ICD-10 Finland
Congestive heart failure
4.0
27.1
117
330
Z51.5
ICD-10 Finland
Palliative care
4.6
26.7
98
237
K92.1
ICD-10 Finland
Melaena
5.2
26.6
86
181
H3600, E103
ICD-10 Finland
NA
19.1
26.4
40
22
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
26.3
138
458
M10.9
ICD-10 Finland
Gout, unspecified
4.3
26.0
104
273
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
269.4
25.9
26
*
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
52.0
25.4
30
6
J01MA14
ATC
moxifloxacin; systemic
3.6
24.9
120
372
H36.01
ICD-10 Finland
Diabetic maculopathy
14.3
24.8
42
31
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
134.5
24.7
26
*
H04AA01
ATC
glucagon; nasal, parenteral
10.2
24.6
49
51
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
24.5
200
888
J01DB01
ATC
cefalexin; oral
2.6
24.4
621
4875
K65.0
ICD-10 Finland
Acute peritonitis
17.3
24.3
38
23
H43.1
ICD-10 Finland
Vitreous haemorrhage
8.9
24.2
52
62
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
26.5
24.1
33
13
B82
ICPC
Anaemia other/unspecified
9.3
23.9
50
57
N17.8
ICD-10 Finland
Other acute renal failure
17.6
23.8
37
22
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
129.1
23.7
25
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.6
23.7
114
352
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.0
23.6
79
173
C10AA05
ATC
atorvastatin; oral
2.2
23.5
358
2184
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.2
23.3
326
1912
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.0
23.0
53
71
KBV00
NOMESCO Finland
Insertion of stent into ureter
19.7
22.8
34
18
PB1AC
NOMESCO Finland
Angiography of upper extremity with X-ray
123.8
22.7
24
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.3
22.7
307
1766
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.9
22.5
52
70
L04AA01
ATC
[U] ciclosporin; systemic
14.9
22.3
37
26
A04AA01
ATC
ondansetron; systemic, rectal
4.4
22.0
84
210
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
30.1
22.0
29
10
S97
ICPC
Chronic ulcer skin
4.6
21.9
79
187
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.3
21.8
120
409
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.1
21.6
49
64
PC5DE
NOMESCO Finland
Ultrasound of kidney circulation with Doppler technic
44.8
21.5
26
6
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.8
21.3
160
672
Z3231
NOMESCO Finland
Registered nurse
2.3
21.2
261
1424
TPH07
NOMESCO Finland
Cathetrisation of artery
3.1
20.9
125
451
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
20.9
150
610
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.2
20.9
120
421
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.9
20.8
89
248
WZC30
NOMESCO Finland
Teaching
2.9
20.7
141
556
R18
ICD-10 Finland
Ascites
9.6
20.6
42
46
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.1
20.4
82
216
H02AB06
ATC
prednisolone; systemic
2.1
20.3
376
2447
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
4.4
20.2
77
192
SPAT1255
SPAT
Intravenous administration of medicine
4.0
20.2
86
238
C03DA01
ATC
spironolactone; oral
3.0
20.2
127
476
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
11.7
20.2
37
33
WX892
NOMESCO Finland
Monitored bed care
3.5
20.1
99
310
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
24.2
20.1
28
12
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
15.9
19.9
32
21
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
9.0
19.9
42
49
A10BH05
ATC
linagliptin; oral
4.4
19.8
75
186
R11
ICD-10 Finland
Nausea and vomiting
3.6
19.6
93
282
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
7.8
19.4
45
61
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
47.3
19.3
23
5
C09CA01
ATC
losartan; oral
2.3
19.3
222
1163
N02BE01
ATC
paracetamol; systemic, rectal
2.4
19.2
638
5258
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
56.5
19.0
22
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
19.0
134
539
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
18.6
152
666
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
30.9
18.4
24
8
NHQ40
NOMESCO Finland
Amputation of toe
9.2
18.3
38
43
UKC02
NOMESCO Finland
Cystoscopy
2.4
18.3
174
824
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
18.1
179
866
M05BX04
ATC
denosumab; parenteral
4.3
17.9
69
174
C08CA02
ATC
felodipine; oral
2.9
17.9
117
447
T90
ICPC
Diabetes non-insulin dependent
2.3
17.8
206
1078
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
68.3
17.8
20
*
JA3FT
NOMESCO Finland
Exchange abdominal catheter with radiological guidance
+∞
17.8
17
*
Z2446
NOMESCO Finland
Social worker
3.7
17.7
81
239
Z99.2
ICD-10 Finland
Dependence on renal dialysis
97.4
17.6
19
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
4.6
17.4
62
145
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
21.5
17.4
25
12
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
6.3
17.2
46
77
R4190
NOMESCO Finland
Nutritional therapy
5.8
17.2
49
89
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
6.4
17.1
45
74
N18
ICD-10 Finland
Chronic kidney disease
9.8
17.1
34
36
I50.1
ICD-10 Finland
Left ventricular failure
4.1
17.0
69
183
H3601, E113
ICD-10 Finland
NA
7.5
17.0
40
56
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.7
16.8
58
131
A06AD11
ATC
lactulose; oral
2.5
16.8
147
665
L03AA13
ATC
pegfilgrastim; parenteral
5.4
16.8
51
100
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
15.5
16.8
27
18
WX204
NOMESCO Finland
Axillary plexus blockaced
5.8
16.8
48
88
A41.8
ICD-10 Finland
Other specified sepsis
8.2
16.7
37
47
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
16.7
94
325
WX002
NOMESCO Finland
Sedation and analgesia
2.3
16.6
185
948
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
23.7
16.5
23
10
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.5
16.5
43
70
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
11.5
16.4
30
27
E86
ICD-10 Finland
Volume depletion
6.6
16.3
42
67
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
4.1
16.3
65
170
H02AB02
ATC
dexamethasone; systemic
2.9
16.2
104
390
H3603, E113
ICD-10 Finland
NA
12.0
16.2
29
25
SPAT1263
SPAT
Sampling
1.9
16.1
332
2184
WW200
NOMESCO Finland
Immunization
6.1
16.1
44
76
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
25.1
16.1
22
9
C08CA13
ATC
lercanidipine; oral
2.6
16.0
131
569
A07AA09
ATC
vancomycin; oral
8.6
15.9
34
41
H25.8
ICD-10 Finland
Other senile cataract
2.6
15.7
127
549
WX882
NOMESCO Finland
High dependency care
5.1
15.7
50
104
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
26.9
15.7
21
8
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
26.9
15.7
21
8
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.1
15.6
210
1165
WW400
NOMESCO Finland
Plasmaferesis
163.3
15.5
16
*
R60.0
ICD-10 Finland
Localized oedema
2.7
15.5
111
446
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
7.3
15.5
37
53
R4180
NOMESCO Finland
Podiatric therapy
15.2
15.4
25
17
WX402
NOMESCO Finland
General anaesthesia
2.5
15.4
138
630
R06.0
ICD-10 Finland
Dyspnoea
2.1
15.4
208
1155
RS220
NOMESCO Finland
NA
9.0
15.3
32
37
ZX112
NOMESCO Finland
Subcutaneous
6.0
15.3
42
73
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
10.7
15.3
29
28
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.0
15.2
62
165
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.5
15.2
54
126
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
12.1
15.2
27
23
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
46.0
15.1
18
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.7
15.1
30
32
L28
ICPC
Limited function/disability (L)
2.4
15.0
146
696
H36.00
ICD-10 Finland
Diabetic background retinopathy
8.5
14.9
32
39
AA1AD
NOMESCO Finland
CT of head and brain
2.1
14.8
216
1236
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
13.6
14.8
25
19
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.2
14.7
79
264
UJF92
NOMESCO Finland
Capsular endoscopy
8.3
14.7
32
40
D630, C61
ICD-10 Finland
NA
+∞
14.6
14
*
ZX121
NOMESCO Finland
Central venous catheter
81.7
14.6
16
*
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
6.4
14.6
38
62
SPAT1229
SPAT
Assessment of need for aid
3.0
14.6
89
325
ZXA00
NOMESCO Finland
Right side
2.0
14.6
238
1423
177
Kela drug reimbursment
Insulin glargine 300 U / ml
6.8
14.5
36
55
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
14.4
286
1834
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
27.8
14.3
19
7
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
14.1
96
373
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.4
14.1
70
221
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.0
14.0
223
1316
Q61.3
ICD-10 Finland
Polycystic kidney, unspecified
24.3
13.8
19
8
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.1
13.8
54
139
KBV10
NOMESCO Finland
Removal of stent from ureter
13.9
13.8
23
17
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
13.8
327
2222
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
13.8
179
969
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
7.8
13.8
31
41
E10
ICD-10 Finland
Type 1 diabetes mellitus
8.6
13.6
29
35
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
76.6
13.6
15
*
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
+∞
13.6
13
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.0
13.5
79
280
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.6
13.5
47
108
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
13.5
153
782
A10AE06
ATC
insulin degludec; parenteral
5.0
13.5
43
90
B01AB05
ATC
enoxaparin; parenteral
1.9
13.4
246
1523
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.9
13.4
241
1482
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.5
13.3
34
54
C07AB02
ATC
metoprolol; systemic
2.0
13.3
197
1124
A10BB12
ATC
glimepiride; oral
2.9
13.3
84
311
GD2SN
NOMESCO Finland
Lung ventilation SPECT
14.1
13.3
22
16
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.2
13.2
50
125
WX872
NOMESCO Finland
Intensive care
3.4
13.2
64
198
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.3
13.2
130
622
A09AA02
ATC
multienzymes (lipase, protease etc.)
6.4
13.2
34
55
B99
ICD-10 Finland
Other and unspecified infectious diseases
5.9
13.1
36
63
128
Kela drug reimbursment
Cancers of female genital organs
9.6
13.1
26
28
H26.3
ICD-10 Finland
Drug-induced cataract
17.1
13.0
20
12
N03AX16
ATC
pregabalin; oral
2.0
13.0
186
1044
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
28.9
13.0
17
6
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.5
12.9
105
452
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
12.9
248
1556
Z3226
NOMESCO Finland
Physiotherapist
2.1
12.9
160
848
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.5
12.9
33
53
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
5.0
12.9
41
86
C09BA02
ATC
enalapril and diuretics; systemic
2.7
12.7
92
371
212
Kela drug reimbursment
Gout
5.5
12.7
37
70
CKC15
NOMESCO Finland
Panretinal photocoagulation
12.6
12.7
22
18
NGQ20
NOMESCO Finland
Amputation of lower leg
15.8
12.7
20
13
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
71.1
12.6
14
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
32.6
12.6
16
5
A28
ICPC
Limited function/disability NOS
2.2
12.5
148
767
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
24.8
12.5
17
7
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.1
12.5
30
44
A10BH01
ATC
sitagliptin; oral
2.6
12.5
92
377
PB1AT
NOMESCO Finland
Upper extremity artery PTA
132.1
12.5
13
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
132.1
12.5
13
*
TKC20
NOMESCO Finland
Catheterisation of bladder
2.8
12.4
83
319
C02CA01
ATC
prazosin; oral
5.5
12.4
36
68
CKC10
NOMESCO Finland
Local photocoagulation of retina
6.1
12.4
33
56
J94.8
ICD-10 Finland
Other specified pleural conditions
6.1
12.4
33
56
ZXA05
NOMESCO Finland
Left side
1.9
12.4
214
1292
CKD40
NOMESCO Finland
Endophotocoagulation of retina
7.6
12.3
28
38
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
38.2
12.2
15
*
R31
ICD-10 Finland
Unspecified haematuria
2.4
12.2
107
482
UJF02
NOMESCO Finland
Peroral enteroscopy
16.2
12.2
19
12
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
18.4
12.1
18
10
K65.8
ICD-10 Finland
Other peritonitis
27.2
12.1
16
6
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.4
12.1
59
184
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.0
12.1
48
126
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.6
12.0
30
47
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
47.5
11.9
14
*
C09CA06
ATC
candesartan; oral
2.1
11.8
159
870
GD1UN
NOMESCO Finland
Lung circulation SPECT
15.0
11.8
19
13
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.3
11.8
116
551
GD1AD
NOMESCO Finland
Thorax CT examination
3.7
11.8
51
144
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.1
11.7
28
41
I15.0
ICD-10 Finland
Renovascular hypertension
16.7
11.7
18
11
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
12.8
11.7
20
16
H05BX02
ATC
paricalcitol; systemic
66.0
11.6
13
*
SPAT1088
SPAT
Blood transfusion
19.3
11.6
17
9
B01AC04
ATC
clopidogrel; oral
2.1
11.6
155
844
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
8.8
11.6
24
28
I35.0
ICD-10 Finland
Aortic (valve) stenosis
3.0
11.6
67
236
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
121.8
11.5
12
*
SPAT1254
SPAT
Administration of medicine
2.2
11.4
129
656
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.9
11.3
209
1284
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
10.8
11.3
21
20
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
8.2
11.1
24
30
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.8
11.1
72
271
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.4
11.0
28
45
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.6
11.0
31
57
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.1
11.0
29
49
RD210
NOMESCO Finland
NA
5.9
11.0
30
53
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
11.0
119
591
H3600, E113
ICD-10 Finland
NA
7.0
10.9
26
38
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
7.0
10.9
26
38
N05CF01
ATC
zopiclone; oral
1.8
10.9
254
1685
ZX100
NOMESCO Finland
Oral
8.4
10.9
23
28
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.8
10.9
45
123
WX203
NOMESCO Finland
Infraclavicular plexus blockade
5.3
10.9
32
62
ZX198
NOMESCO Finland
Other local administration
9.0
10.8
22
25
WX610
NOMESCO Finland
Patient controlled analgesia
18.1
10.8
16
9
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
28.5
10.8
14
5
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
28.5
10.8
14
5
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
4.5
10.7
37
85
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.8
10.7
70
266
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
21.8
10.7
15
7
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
10.7
346
2525
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.2
10.7
55
179
C09AA05
ATC
ramipril; oral
1.8
10.7
220
1399
AN1
HP
Coronary angiography
2.2
10.7
119
597
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.6
10.6
36
82
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
6.3
10.5
27
44
C10AA01
ATC
simvastatin; oral
1.7
10.5
357
2638
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
10.4
10
*
N08.5*M31.7
ICD-10 Finland
Glomerular disease states in microscopic polyangiitis
+∞
10.4
10
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
10.4
141
773
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
9.8
10.3
20
21
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
19.1
10.3
15
8
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
19.1
10.3
15
8
E66.00
ICD-10 Finland
Metabolic syndrome
3.2
10.3
53
173
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
23.7
10.3
14
6
WX110
NOMESCO Finland
Local anesthesy
1.7
10.2
465
3711
R04.0
ICD-10 Finland
Epistaxis
2.7
10.2
71
281
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
10.2
67
256
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.1
10.2
22
28
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
5.1
10.1
31
63
S92.3
ICD-10 Finland
Fracture of metatarsal bone
4.7
10.1
33
72
ZZA00
NOMESCO Finland
Split skin graft
4.0
10.0
39
101
PB1AE
NOMESCO Finland
Ultrasound examination of arteries of upper extremity
40.6
10.0
12
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
7.8
10.0
22
29
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
9.9
56
193
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.4
9.9
35
83
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
12.4
9.9
17
14
JN4BD
NOMESCO Finland
Extensive body CT
2.2
9.8
99
476
Z94.4
ICD-10 Finland
Liver transplant status
20.3
9.8
14
7
R53
ICD-10 Finland
Malaise and fatigue
1.9
9.7
155
897
G63.8*N18.8
ICD-10 Finland
Uraemic neuropathy
55.7
9.7
11
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.1
9.6
51
170
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
9.6
255
1743
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
9.6
61
229
NF3AA
NOMESCO Finland
Femur X-ray examination
5.6
9.6
27
50
C01DA14
ATC
isosorbide mononitrate; oral
1.9
9.6
154
895
TQW80
NOMESCO Finland
Local dermatologic skincare
4.6
9.6
32
72
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
15.3
9.5
15
10
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.6
9.5
68
275
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.2
9.5
48
155
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
30.4
9.4
12
*
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
+∞
9.4
9
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
8.2
9.4
20
25
R80
ICD-10 Finland
Isolated proteinuria
8.2
9.4
20
25
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
5.0
9.4
29
60
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
9.3
220
1452
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
9.3
306
2218
M01AH05
ATC
etoricoxib; oral
0.6
9.3
208
2931
ZXE00
NOMESCO Finland
One hour or less
1.7
9.2
283
2013
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.8
9.2
22
33
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
6.8
9.2
22
33
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
7.9
9.2
20
26
C10AA04
ATC
fluvastatin; oral
2.3
9.2
89
418
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
9.1
68
280
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
11.6
9.1
16
14
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.9
9.1
56
204
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.4
9.1
32
76
C02EA02
ATC
NA
2.9
9.1
56
205
XF602
NOMESCO Finland
Bloodpressure monitoring
9.2
9.1
18
20
TPX15
NOMESCO Finland
Removal of vascular injection port
15.8
9.1
14
9
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
37.2
9.0
11
*
Z94.1
ICD-10 Finland
Heart transplant status
18.9
9.0
13
7
K55.8
ICD-10 Finland
Other vascular disorders of intestine
24.3
8.9
12
5
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
12.7
8.9
15
12
J04AB02
ATC
rifampicin; systemic
8.1
8.9
19
24
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.7
8.9
29
64
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
8.9
88
421
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
8.9
83
386
RS221
NOMESCO Finland
NA
6.4
8.8
22
35
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.8
8.8
164
999
C08CA05
ATC
nifedipine; systemic
2.5
8.8
66
274
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.7
8.8
37
104
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.5
8.7
40
120
R33
ICD-10 Finland
Retention of urine
2.3
8.7
80
368
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
14.2
8.7
14
10
L01AA01
ATC
cyclophosphamide; systemic
14.2
8.7
14
10
H02AB09
ATC
hydrocortisone; systemic
5.1
8.7
26
52
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
8.6
84
398
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
8.6
81
377
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
27.9
8.5
11
*
E21.1
ICD-10 Finland
Secondary hyperparathyroidism, not elsewhere classified
27.9
8.5
11
*
D69.5
ICD-10 Finland
Secondary thrombocytopenia
20.3
8.5
12
6
Z00.8
ICD-10 Finland
Other general examinations
2.6
8.5
61
247
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.7
8.5
36
102
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
8.4
135
781
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
91.0
8.4
9
*
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
91.0
8.4
9
*
PC6DE
NOMESCO Finland
NA
91.0
8.4
9
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
8.4
263
1868
SPAT1164
SPAT
Haemodialysis
+∞
8.3
8
*
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
+∞
8.3
8
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.3
131
754
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
4.1
8.3
31
78
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.8
8.3
34
93
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
8.7
8.3
17
20
A02BC01
ATC
omeprazole; systemic
1.7
8.3
208
1387
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.2
8.3
19
27
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
8.3
41
131
B01AB04
ATC
dalteparin; parenteral
2.9
8.3
49
177
L03AA02
ATC
filgrastim; parenteral
4.2
8.3
30
74
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
7.7
8.2
18
24
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
7.7
8.2
18
24
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.9
8.2
135
791
B03BA03
ATC
hydroxocobalamin; parenteral
2.6
8.2
57
228
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
8.1
146
880
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.7
8.1
55
215
XX_20
NOMESCO Finland
Bioimpedance measurement
33.7
8.1
10
*
KAC00
NOMESCO Finland
Nephrectomy
17.4
8.1
12
7
KA3EB
NOMESCO Finland
Antegrade pyelography
10.2
8.1
15
15
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
10.2
8.1
15
15
163
Kela drug reimbursment
Abiraterone and enzalutamide
6.0
8.0
21
36
I70.1
ICD-10 Finland
Atherosclerosis of renal artery
22.3
8.0
11
5
J01CF05
ATC
flucloxacillin; systemic
3.5
8.0
36
107
130
Kela drug reimbursment
Malignant tumour
2.2
8.0
80
384
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
7.3
8.0
18
25
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.3
8.0
72
328
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.2
7.9
83
404
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
3.1
7.9
41
136
QDA10
NOMESCO Finland
Incision of skin of lower limb
13.2
7.9
13
10
M86.6
ICD-10 Finland
Other chronic osteomyelitis
13.2
7.9
13
10
K05.31
ICD-10 Finland
Periodontitis pronounced
2.2
7.9
83
405
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
4.8
7.9
25
54
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.4
7.8
36
109
K07
ICPC
Swollen ankles/oedema
3.1
7.8
41
137
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
10.9
7.8
14
13
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
10.9
7.8
14
13
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
9.5
7.8
15
16
WX140
NOMESCO Finland
Parabulbar anesthesy
2.9
7.8
45
160
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
45.5
7.7
9
*
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
45.5
7.7
9
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.6
7.7
33
95
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
25.3
7.6
10
*
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
25.3
7.6
10
*
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
25.3
7.6
10
*
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
25.3
7.6
10
*
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
4.7
7.6
24
52
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
10.2
7.6
14
14
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.2
7.6
27
66
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
3.9
7.5
29
76
116
Kela drug reimbursment
Prostate cancer
2.3
7.5
69
319
E0000UV
ATC
NA
1.6
7.5
260
1885
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
7.5
52
208
Z50.1
ICD-10 Finland
Other physical therapy
2.7
7.5
48
183
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.4
7.4
34
103
JDA42
NOMESCO Finland
Other endoscopic haemostatic procedure in stomach or pylorus
80.9
7.4
8
*
C03AA03
ATC
hydrochlorothiazide; oral
2.1
7.4
84
423
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
7.4
94
499
A04AA02
ATC
granisetron; systemic, transdermal
2.6
7.4
51
203
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.1
7.3
27
68
HA1AA
NOMESCO Finland
X-ray mammography
2.7
7.3
48
186
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
9.5
7.3
14
15
D638, N185
ICD-10 Finland
NA
+∞
7.3
7
*
N0830, E102
ICD-10 Finland
NA
+∞
7.3
7
*
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
+∞
7.3
7
*
V03AE05
ATC
sucroferric oxyhydroxide; oral
+∞
7.3
7
*
E102N
ICD-10 Finland
NA
+∞
7.3
7
*
N08.5*M31.0
ICD-10 Finland
Glomerular disorders in Goodpasture's syndrome
+∞
7.3
7
*
C09CA07
ATC
telmisartan; oral
2.4
7.3
62
274
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
6.3
7.3
18
29
L02BB04
ATC
enzalutamide; oral
6.3
7.3
18
29
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.8
7.2
43
157
WX725
NOMESCO Finland
Noninvasive ventilation
2.8
7.2
46
174
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
30.3
7.2
9
*
L04AA05
ATC
[U] tacrolimus; systemic
30.3
7.2
9
*
I51.1
ICD-10 Finland
Rupture of chordae tendineae, not elsewhere classified
30.3
7.2
9
*
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
20.2
7.1
10
5
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.9
7.1
41
145
P01AB01
ATC
metronidazole; oral, rectal
1.6
7.1
244
1758
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
7.1
129
775
K83.0
ICD-10 Finland
Cholangitis
5.7
7.1
19
34
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
12.2
7.1
12
10
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
7.1
180
1201
K92.0
ICD-10 Finland
Haematemesis
3.7
7.0
29
81
KAC10
NOMESCO Finland
Total nephrectomy with capsule
7.1
7.0
16
23
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.7
7.0
45
171
B01AA03
ATC
warfarin; systemic
1.7
7.0
179
1195
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
7.0
75
372
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.2
7.0
20
39
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
7.0
46
179
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.4
7.0
17
27
G72.8
ICD-10 Finland
Other specified myopathies
5.5
6.9
19
35
H26.2
ICD-10 Finland
Complicated cataract
5.9
6.9
18
31
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.7
6.9
28
77
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
13.9
6.9
11
8
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.9
130
792
M10
ICD-10 Finland
Gout
2.7
6.8
44
168
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
6.8
51
212
JAH00
NOMESCO Finland
Laparotomy
3.4
6.8
31
94
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
6.8
72
355
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
6.8
461
5315
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
11.1
6.8
12
11
E87.2
ICD-10 Finland
Acidosis
11.1
6.8
12
11
ZXA10
NOMESCO Finland
Bilateral
1.7
6.8
147
935
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
9.4
6.8
13
14
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.9
6.8
39
138
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
40.4
6.8
8
*
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
40.4
6.8
8
*
N18.4
ICD-10 Finland
Chronic kidney disease, stage 4
16.9
6.8
10
6
RJ410
NOMESCO Finland
NA
16.9
6.8
10
6
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
4.2
6.7
24
59
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
7.3
6.7
15
21
A10BA02
ATC
metformin; oral
1.6
6.7
207
1450
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.3
6.7
23
55
H26.02
ICD-10 Finland
Presenil cataract
3.7
6.6
27
75
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.4
6.6
53
229
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
12.4
6.6
11
9
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.5
6.6
29
86
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.5
6.6
49
203
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.2
6.5
61
285
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
6.9
6.5
15
22
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.9
6.5
25
66
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
5.1
6.5
19
38
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.1
6.5
19
38
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.6
6.5
21
47
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
3.3
6.5
31
98
S91.3
ICD-10 Finland
Open wound of other parts of foot
3.6
6.4
27
77
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
70.4
6.4
7
*
M86.4
ICD-10 Finland
Chronic osteomyelitis with draining sinus
70.4
6.4
7
*
TK823
NOMESCO Finland
Peritoneal permeability analysis
70.4
6.4
7
*
PWG00
NOMESCO Finland
Reoperation on peripheral vessels for thrombosis or embolism
70.4
6.4
7
*
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
70.4
6.4
7
*
H3603, E107
ICD-10 Finland
NA
70.4
6.4
7
*
B81
ICPC
Anaemia vit B12/folate deficiency
2.8
6.4
39
145
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
3.8
6.4
25
67
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
6.4
51
218
R60.9
ICD-10 Finland
Oedema, unspecified
2.7
6.4
42
163
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
5.0
6.4
19
39
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.9
6.4
96
542
A79
ICPC
Malignancy NOS
5.2
6.3
18
35
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.7
6.3
41
157
D50.8
ICD-10 Finland
Other iron deficiency anaemias
6.0
6.3
16
27
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
11.1
6.3
11
10
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
6.3
38
141
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
18.2
6.3
9
5
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
18.2
6.3
9
5
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
18.2
6.3
9
5
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
18.2
6.3
9
5
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
18.2
6.3
9
5
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
18.2
6.3
9
5
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
18.2
6.3
9
5
G99.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy
+∞
6.3
6
*
E112N
ICD-10 Finland
NA
+∞
6.3
6
*
PBU99
NOMESCO Finland
Other repair after previous reconstruction of arteries of upper extremity
+∞
6.3
6
*
K76.6
ICD-10 Finland
Portal hypertension
+∞
6.3
6
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
+∞
6.3
6
*
Z49
ICD-10 Finland
Care involving dialysis
+∞
6.3
6
*
M31.7
ICD-10 Finland
Microscopic polyangiitis
+∞
6.3
6
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.3
6.2
54
244
7151
FHL
Kidney transplantation
26.9
6.2
8
*
NH3BG
NOMESCO Finland
MRI of foot
26.9
6.2
8
*
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
26.9
6.2
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
4.0
6.2
23
59
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
5.8
6.2
16
28
A06AH03
ATC
naloxegol; oral
5.8
6.2
16
28
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
6.2
118
723
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
3.6
6.2
26
75
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
7.8
6.1
13
17
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
7.8
6.1
13
17
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
2.3
6.1
53
240
L02BB03
ATC
bicalutamide; oral
2.8
6.1
37
138
SPAT1301
SPAT
No procedures
1.5
6.1
224
1629
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
8.7
6.1
12
14
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.2
6.1
57
267
RJ411
NOMESCO Finland
NA
10.1
6.0
11
11
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
10.1
6.0
11
11
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.2
6.0
21
51
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
6.0
57
268
XKD00
NOMESCO Finland
Uroflowmetry
1.7
6.0
144
940
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.0
6.0
78
416
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.8
6.0
36
133
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
454
721
12.56
309.70
4.5
4.4
u/l
250.3
238.6
0.69
435
685
(3003458) Phosphate [Moles/volume] in Serum or Plasma
568
927
16.91
307.65
34.0
5.7
mmol/l
1.3
1.0
45.67
557
853
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
567
839
18.81
307.65
11.2
2.3
%
23.6
22.7
0.82
522
716
(3004789) Transferrin [Mass/volume] in Serum or Plasma
590
896
19.87
307.65
11.0
2.2
g/l
1.9
2.3
45.74
578
830
(3022948) Iron [Moles/volume] in Serum or Plasma
596
979
18.62
307.65
11.1
2.3
umol/l
11.3
13.0
6.87
583
909
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
360
253
24.19
307.65
2.5
2.0
g/l
1.5
1.5
0.15
324
225
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
459
506
18.85
307.65
14.3
4.0
ng/l
188.2
85.7
33.30
437
454
(3020779) Urea [Moles/volume] in Serum or Plasma
536
614
22.45
307.65
37.0
7.3
mmol/l
16.8
10.3
43.28
524
588
(3027945) Reticulocytes/100 erythrocytes in Blood
428
759
10.48
261.14
5.0
2.4
%
1.9
1.7
4.26
399
685
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
230
185
16.76
245.44
8.0
4.6
mg/l
2.4
1.6
15.38
206
169
(40768446) Kidney Pathology biopsy report
128
18
83.75
240.21
2.0
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
355
557
10.32
237.46
5.7
2.3
e9/l
65.4
67.5
0.47
313
431
(3026250) Tacrolimus [Mass/volume] in Blood
135
30
53.45
233.16
42.1
28.0
ug/l
7.4
7.1
0.32
127
24
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
190
119
20.35
230.83
11.9
6.8
iu/ml
2446.2
392.8
0.49
69
18
(3012095) Magnesium [Moles/volume] in Serum or Plasma
464
1071
8.47
217.13
8.6
3.6
mmol/l
0.8
0.8
0.62
448
1008
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
171
98
21.67
216.19
5.7
3.5
u/ml
10134.8
510.9
—
13
8
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
174
112
19.34
207.86
2.6
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
174
113
19.17
206.91
1.8
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
167
101
20.40
205.58
2.8
1.6
u/ml
115.7
105.4
0.45
52
15
(3002032) Base excess in Venous blood by calculation
359
670
8.62
203.36
16.3
3.8
mmol/l
0.8
2.0
7.31
306
529
(3042733) HLA Ab [Presence] in Serum
108
19
65.10
194.72
7.0
5.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
165
110
18.43
193.22
1.9
1.3
u/ml
249.5
291.4
0.45
115
61
(3017143) Hepatitis C virus Ab [Presence] in Serum
328
598
8.37
188.31
4.5
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
301
514
8.58
182.85
12.5
4.3
kpa
4.9
5.2
5.37
296
472
(3009343) pH of Capillary blood
299
508
8.60
182.42
12.5
4.4
ph
7.4
7.4
0.76
45
59
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
291
483
8.70
181.14
12.4
4.4
mmol/l
-0.2
1.9
11.90
210
355
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
530
1635
7.10
177.10
3.9
2.0
mg/l
3.1
3.0
1.04
488
1378
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
155
108
17.38
176.93
9.5
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
179
165
13.52
173.53
1.8
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
121
52
27.03
171.46
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
333
681
7.45
169.69
4.5
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
121
56
25.08
166.53
2.3
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
648
2517
7.94
165.18
11.6
2.5
ug/l
387.1
146.6
21.98
630
2274
(3000991) Gas panel - Venous blood
307
607
7.40
160.81
17.3
9.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
294
566
7.46
157.75
5.4
2.7
g/l
62.9
66.5
9.55
280
516
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
209
287
9.37
151.01
2.7
1.8
ug/l
2.4
1.5
0.70
202
248
(46235355) HIV 1 and 2 tests - Meaningful Use set
343
806
6.51
149.55
4.5
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
226
346
8.57
148.94
13.3
4.3
mmol/l
23.2
24.0
2.36
208
315
(3024561) Albumin [Mass/volume] in Serum or Plasma
680
2943
7.95
147.99
23.4
4.8
g/l
32.4
35.2
29.83
669
2742
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
152
139
13.14
147.30
1.6
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
553
2004
6.17
147.17
9.5
4.1
—
—
—
0
0
(3024471) HLA-A [Type]
87
21
46.11
146.26
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
87
21
46.11
146.26
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
442
1380
5.66
138.28
2.8
1.7
nmol/l
1224.4
1171.9
0.49
386
1026
(40760888) Immunoglobulin light chains.free panel - Serum
149
148
12.03
136.44
2.0
3.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
504
1774
5.62
136.10
7.7
2.7
umol/l
3668.4
7843.2
1.27
482
1510
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
72
13
60.50
128.37
1.1
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
376
1082
5.49
127.84
4.5
2.5
s
29.2
30.1
1.80
366
1054
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
73
15
53.22
126.89
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
161
198
9.83
125.98
6.1
3.3
mmol/l
21.9
25.0
10.05
153
168
(3042936) Bacteria identified in Isolate by Culture
353
980
5.50
124.78
3.6
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
236
453
6.86
124.63
2.1
2.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
250
511
6.55
123.84
6.3
3.9
%
0.9
0.9
0.17
133
152
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
692
3386
6.99
120.36
49.6
6.9
mmol/l
1.2
1.2
7.41
617
2862
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
246
510
6.41
119.77
2.6
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
159
205
9.34
119.66
2.1
3.5
ratio
1.6
2.0
—
10
22
(3002179) Metamyelocytes/100 leukocytes in Blood
233
462
6.60
118.69
5.9
3.8
%
0.9
0.4
1.35
106
109
(3037121) Protein [Mass/volume] in Urine
178
266
8.23
118.39
9.6
3.0
g/l
0.7
0.2
6.45
146
113
(3034860) Kappa light chains.free [Mass/volume] in Serum
159
210
9.11
117.28
2.2
3.5
mg/l
89.9
87.7
0.03
118
172
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
159
210
9.11
117.28
2.2
3.5
mg/l
68.2
48.7
0.57
118
174
(3021440) Promyelocytes/100 leukocytes in Blood
235
483
6.37
115.11
6.5
4.0
%
0.1
0.1
0.42
131
138
(42870588) Differential panel, method unspecified - Blood
533
2167
5.01
114.85
11.2
5.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
134
147
10.66
113.85
8.8
3.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
87
45
21.46
113.54
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
171
257
8.10
112.93
4.8
4.7
u/ml
0.2
0.4
4.22
99
139
(3006504) Eosinophils/100 leukocytes in Blood
629
2965
5.50
110.57
13.4
5.5
%
2.9
2.9
0.13
614
2765
(3044640) Blood type and Crossmatch panel - Blood
517
2102
4.81
110.07
6.1
2.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
619
2890
5.37
109.90
13.0
5.6
%
0.6
0.6
1.73
606
2697
(3019069) Monocytes/100 leukocytes in Blood
630
2986
5.47
109.61
14.1
5.8
%
9.0
8.9
0.26
615
2793
(3014148) Varicella zoster virus Ab [Titer] in Serum
89
54
18.32
107.83
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
571
2543
4.91
106.70
12.4
3.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
630
3042
5.31
105.42
13.8
5.7
%
21.6
26.8
22.85
616
2827
(3007853) Bacteria identified in Skin by Aerobe culture
290
786
5.11
103.01
3.3
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
216
454
6.06
102.50
6.0
4.0
%
0.0
0.1
0.48
113
120
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
565
2569
4.68
100.73
5.1
2.2
nmol/l
76.0
77.6
0.67
549
2243
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
103
92
12.62
100.35
8.5
7.4
mg/l
11.6
11.6
0.00
97
83
(3022313) Gas panel - Capillary blood
195
382
6.35
99.44
14.9
4.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
614
2998
4.92
98.67
13.2
5.5
%
62.6
57.9
17.89
598
2805
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
88
63
15.49
97.70
1.3
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
494
2073
4.37
97.42
7.1
2.5
u/l
59.2
57.2
0.50
474
1906
(3026782) Osmolality of Urine
394
1410
4.39
96.80
8.4
2.7
mosm/kgh2o
454.4
569.0
35.27
370
1184
(3004809) Band form neutrophils/100 leukocytes in Blood
102
96
11.96
95.97
4.2
3.6
%
1.3
1.7
0.28
86
81
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
661
3475
5.27
94.68
13.1
6.2
umol/l
9.2
12.5
10.04
645
3296
(3006315) Basophils [#/volume] in Blood
623
3165
4.77
92.50
12.4
5.5
e9/l
0.0
0.0
0.99
598
2730
(3021901) Oxygen saturation in Capillary blood
115
135
9.71
92.39
5.6
2.8
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
504
2208
4.22
92.04
11.1
3.9
mg/mmol
71.5
8.3
20.49
455
1401
(3001604) Monocytes [#/volume] in Blood
620
3156
4.71
91.34
12.4
5.5
e9/l
0.6
0.6
2.85
596
2709
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
261
711
4.88
90.95
6.6
3.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
179
351
6.21
90.73
17.1
3.2
mmol/l
23.6
25.3
8.50
174
339
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
607
3052
4.59
90.71
10.2
4.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
627
3234
4.73
90.28
12.8
5.5
e9/l
1.5
1.9
13.12
604
2837
(3002582) Erythrocytes [#/volume] in Urine
495
2165
4.14
90.05
9.8
3.2
e6/l
40.6
74.2
2.14
465
1681
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
82
61
14.79
88.98
1.6
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
589
2935
4.39
88.18
21.6
9.9
inr
1.3
1.3
0.68
174
813
(3013115) Eosinophils [#/volume] in Blood
626
3268
4.62
87.51
12.8
5.7
e9/l
0.2
0.2
0.85
601
2870
(3013650) Neutrophils [#/volume] in Blood by Automated count
671
3714
5.05
85.86
18.6
8.5
e9/l
4.5
4.2
2.30
650
3243
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
135
220
7.12
81.83
1.7
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
599
3123
4.22
81.51
32.7
6.4
mmol/l
1.2
1.2
1.79
581
2813
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
129
212
7.01
77.43
1.6
1.6
titre
200.0
215.0
—
7
8
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
210
545
4.81
76.58
20.3
3.2
mmol/l
1.2
1.2
4.92
205
476
(40767503) Oxygen content in Capillary blood by calculation
104
137
8.53
75.89
5.6
2.2
%
14.5
16.5
4.51
76
75
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
121
190
7.27
75.74
2.7
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
449
2006
3.67
75.42
5.4
3.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
328
1206
3.83
74.02
2.7
1.8
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
165
363
5.41
73.00
1.8
1.6
g/l
1.0
1.4
1.42
147
334
(3030467) Casts [#/volume] in Urine by Automated count
440
1981
3.57
72.21
9.5
3.1
e6/l
0.4
0.5
0.45
391
1499
(3005719) IgG [Mass/volume] in Serum or Plasma
186
459
4.92
71.85
3.4
2.7
g/l
9.7
10.9
2.37
171
417
(3018095) Leukocytes [#/volume] in Urine
502
2460
3.60
71.84
11.2
3.7
e6/l
104.8
90.7
0.20
469
1786
(3000850) Epithelial cells [#/volume] in Urine
371
1511
3.61
71.11
7.2
2.5
e6/l
4.5
4.2
0.18
355
1317
(3009508) Creatinine [Moles/volume] in Urine
465
2192
3.52
70.41
9.2
3.0
mmol/l
5.3
7.7
52.08
436
1798
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
384
1610
3.56
70.11
5.5
2.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
171
402
5.09
69.90
2.2
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
450
2095
3.48
69.21
9.0
3.2
mg/l
594.9
166.9
1.75
403
1351
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
74
72
11.18
67.67
9.0
2.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
356
1467
3.48
66.04
2.2
1.7
pmol/l
466.8
8097259.0
0.79
322
1198
(3014576) Chloride [Moles/volume] in Serum or Plasma
266
909
3.82
65.87
12.2
7.5
mmol/l
103.8
104.2
0.54
261
890
(3018418) pH of Serum or Plasma
433
2033
3.34
64.46
21.1
3.8
ph
7.4
7.4
3.99
123
375
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
109
184
6.66
63.40
4.1
3.3
g/l
3.7
3.6
0.15
104
179
(3024928) Oxygen saturation in Venous blood
97
147
7.33
62.42
9.5
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
656
4034
3.88
61.20
15.7
5.0
mmol/l
7.7
6.8
12.63
642
3796
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
125
258
5.52
58.88
1.8
2.5
g/l
7.3
7.3
0.07
72
196
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
64
7
98.90
58.77
8.3
7.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
92
141
7.21
58.52
11.2
4.0
mmol/l
2.4
2.8
0.63
63
99
(3019832) Treponema pallidum Ab [Presence] in Serum
142
330
4.98
58.34
3.6
1.6
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
257
5.49
58.11
1.8
2.5
g/l
3.4
3.7
1.56
68
188
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
124
258
5.47
57.86
1.8
2.5
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
135
303
5.12
57.77
8.3
6.3
%
1.6
1.6
0.12
130
284
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
203
625
3.97
57.74
3.4
2.4
g/l
0.2
0.2
0.25
181
585
(3021960) Folate [Moles/volume] in Serum or Plasma
371
1674
3.18
57.57
2.1
1.5
nmol/l
20.8
20.5
0.11
342
1402
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
78
101
8.41
57.42
1.2
1.2
u/l
61.0
25.4
0.67
73
87
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
518
2829
3.18
57.35
3.2
2.0
pmol/l
102.2
94.0
3.15
345
1428
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
294
1159
3.37
57.23
7.7
3.0
e6/l
2.1
1.6
0.41
222
669
(3015377) Calcium [Moles/volume] in Serum or Plasma
452
2296
3.10
56.71
10.7
3.3
mmol/l
2.3
2.3
12.73
425
1980
(3033705) Calcium.ionized [Moles/volume] in Venous blood
77
101
8.29
56.06
6.2
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
88
135
7.17
55.87
1.3
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
52
40
13.79
54.97
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
52
40
13.79
54.97
1.9
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
99
178
6.17
53.86
2.1
1.4
g/l
0.3
0.2
1.47
90
169
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
45
28
16.93
53.30
1.3
1.0
u/l
91.3
102.0
0.18
39
20
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
45
28
16.93
53.30
1.3
1.0
u/l
28.4
35.7
0.21
38
19
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
48
34
14.91
53.13
1.6
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
90
8.53
53.12
1.3
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
391
1897
2.99
52.16
8.1
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
61
65
10.04
52.14
3.5
3.3
%
66.5
51.8
3.51
44
49
(3010421) pH of Blood
96
173
6.14
52.07
12.0
3.7
ph
7.4
7.4
4.19
88
138
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
57
56
10.85
51.59
1.3
1.1
u/l
77.5
115.6
0.28
24
39
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
94
168
6.18
51.40
1.9
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
99
188
5.84
50.82
2.1
1.4
g/l
1.0
1.2
2.60
90
178
(4035726)
181
559
3.85
50.77
1.6
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
193
623
3.73
50.73
11.0
8.3
mmol/l
1.3
1.4
0.67
184
594
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
44
29
15.96
50.58
2.0
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
44
29
15.96
50.58
2.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
67
87
8.28
49.10
1.6
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
678
4552
3.56
48.67
14.5
4.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
39
22
18.54
48.36
3.8
2.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
89
162
6.03
47.69
1.9
1.7
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
421
2202
2.83
47.67
5.4
3.1
ng/l
8356.6
1482.5
21.23
401
1897
(3021879) Hepatitis B virus core Ab [Presence] in Serum
139
371
4.29
47.56
2.2
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
85
149
6.24
47.32
3.9
2.6
umol/l
30.3
34.2
0.88
67
126
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
70
100
7.55
47.26
1.6
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
62
77
8.62
47.09
1.3
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
51
49
11.02
46.81
1.5
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
108
239
5.04
46.65
1.9
2.5
g/l
9.5
10.8
1.82
96
207
(3008757) Leukocyte morphology finding [Identifier] in Blood
63
81
8.33
46.51
3.3
3.9
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
722
5102
4.00
46.45
25.5
7.3
u/l
104.3
79.9
12.45
712
4754
(3037522) Nuclear Ab [Titer] in Serum
210
756
3.37
46.25
1.5
1.3
titre
434.7
468.9
0.10
45
169
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
31
11
29.23
46.00
10.9
11.0
mmol/l
5.0
6.5
0.83
31
11
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
40
27
15.51
45.35
1.9
2.6
u/ml
206.4
88552.6
—
8
5
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
35
18
20.25
45.18
1.5
1.0
miu/ml
1575.3
1886.9
0.41
35
18
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
74
118
6.78
45.15
1.5
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
282
1229
2.95
44.46
7.3
2.8
e6/l
0.9
1.1
0.83
212
732
(3011648) Oxygen content in Venous blood
49
48
10.78
44.36
5.6
1.9
%
11.1
11.1
0.00
49
48
(3023199) Leukocytes [#/volume] in Pleural fluid
65
92
7.58
44.20
1.5
1.4
e6/l
1383.4
2212.5
0.53
58
63
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
59
75
8.39
43.93
3.2
1.6
pg
32.8
33.1
0.17
59
75
(40760892) CBC W Ordered Manual Differential panel - Blood
292
1310
2.89
43.48
10.3
4.4
—
—
—
0
0
(3013512) EKG study
392
2055
2.71
43.02
8.0
4.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
51
56
9.63
42.54
2.6
2.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
95
204
5.12
42.40
7.3
4.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
390
2053
2.68
42.25
6.0
3.3
u/l
30.7
35.1
1.48
371
1950
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
469
2712
2.66
41.79
8.0
3.7
ng/l
88.9
47.9
4.93
431
1998
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
115
296
4.34
41.05
2.7
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
110
274
4.47
40.96
2.5
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
81
156
5.64
40.78
4.3
1.9
g/l
113.4
132.0
8.95
74
113
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
76
140
5.87
40.10
1.9
1.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
167
571
3.40
39.47
2.5
2.0
nmol/l
352.2
380.1
1.05
156
524
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
70
121
6.22
39.41
1.8
1.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
198
759
3.11
38.63
11.1
9.1
%
94.9
95.4
0.63
187
729
(3028308) Erythrocytes [#/volume] in Pleural fluid
57
82
7.39
38.14
1.5
1.4
e6/l
38872.4
75956.0
0.51
42
49
(3003694) ABO and Rh group [Type] in Blood
325
1627
2.63
38.14
1.7
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
41
39
11.00
37.79
1.1
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
26
10
26.80
37.41
1.5
1.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
332
1695
2.59
37.23
8.9
4.2
%
93.2
86.3
4.12
325
1654
(3022493) Free Hemoglobin [Mass/volume] in Plasma
38
33
12.01
37.15
9.9
5.2
mg/l
39.1
96.7
1.69
23
27
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
60
94
6.80
37.13
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
98
241
4.47
36.99
2.0
2.6
g/l
3.0
3.1
0.29
69
192
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
190
728
3.08
36.96
2.7
4.1
ug/l
182.5
27.4
0.53
163
602
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
207
837
2.96
36.55
10.9
8.7
kpa
4.9
5.1
1.66
193
801
(3027801) Oxygen [Partial pressure] in Arterial blood
207
837
2.96
36.55
10.8
8.7
kpa
11.6
12.0
0.41
193
803
(3041096) Erythrocytes [Presence] in Urine by Automated
328
1690
2.55
35.79
10.8
3.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
629
4378
2.75
35.71
9.7
4.6
e6/l
45.5
2497.9
1.46
13
82
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
378
2082
2.49
35.69
2.8
2.1
u/l
169.9
265.6
1.44
358
1950
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
55
82
7.11
35.62
1.9
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
59
95
6.61
35.56
2.0
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
55
83
7.02
35.22
1.9
1.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
249
1131
2.71
35.10
1.9
1.4
g/l
2.8
2.6
0.93
186
663
(3003396) Base excess in Arterial blood by calculation
204
838
2.90
34.83
11.0
8.7
mmol/l
-0.3
1.2
4.67
144
652
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
55
84
6.94
34.83
1.9
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
47
61
8.10
34.32
1.4
2.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
192
771
2.93
34.12
4.3
2.9
umol/l
12.0
9.5
0.43
159
686
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
282
1383
2.57
33.81
3.4
1.8
mg/l
2.8
1.3
2.21
248
1080
(3025468) Yersinia sp identified in Specimen by Organism specific culture
54
84
6.80
33.61
2.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
54
85
6.72
33.23
2.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
54
85
6.72
33.23
2.0
1.4
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
37
37
10.42
32.91
1.6
1.5
u/l
4.8
7.3
0.32
13
20
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
14
19.13
32.72
1.3
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
52
81
6.78
32.31
1.5
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
59
105
5.97
32.17
2.2
1.2
—
—
—
0
0
(3019225) pH of Specimen
172
673
2.96
31.86
37.4
4.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
56
96
6.18
31.71
1.4
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
490
3147
2.34
31.29
14.2
5.0
estimate
0.0
0.0
0.00
134
583
(3009261) Glucose [Presence] in Urine by Test strip
493
3185
2.33
30.89
9.6
3.8
estimate
0.0
0.0
0.00
122
561
(3021589) Normoblasts [#/volume] in Blood
455
2849
2.31
30.62
35.4
9.2
e9/l
0.0
0.0
0.12
403
2330
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
49
76
6.79
30.55
2.0
1.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
197
846
2.74
30.54
2.3
1.7
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
107
323
3.65
30.29
1.6
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
42
56
7.84
29.95
2.9
2.2
ml
967.5
619.2
2.97
27
36
(3036489) Thrombin time
87
229
4.12
29.90
2.5
2.6
s
23.0
22.2
0.51
74
216
(40768806) Pleura Pathology biopsy report
52
88
6.23
29.81
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
111
353
3.47
28.99
13.3
3.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
79
200
4.26
28.57
1.7
1.4
ug/g
219.5
280.0
1.74
47
120
(3035350) Ketones [Presence] in Urine by Test strip
484
3166
2.25
28.57
9.5
3.7
estimate
0.0
0.0
0.00
132
579
(40761535) Cells panel - Urine sediment
154
607
2.88
27.90
9.7
3.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
74
182
4.36
27.78
2.3
1.5
iu/ml
0.1
30.1
0.49
11
40
(3011412) CD3 cells [#/volume] in Blood
40
55
7.59
27.77
2.0
2.0
e9/l
0.9
1.1
0.31
23
28
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
140
529
2.98
27.36
6.4
2.8
ml/min/173m2
30.3
62.6
20.54
95
228
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
89
254
3.80
27.28
3.2
3.0
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
23
14
16.86
27.25
6.4
2.3
mmol/l
1.2
1.2
0.08
23
14
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
191
855
2.60
26.93
2.5
1.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
36
46
8.13
26.57
2.3
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
34
41
8.60
26.28
3.2
2.1
min
507.2
493.9
0.35
24
30
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
30
31
10.00
26.01
1.6
1.3
%
63.0
58.5
0.17
24
20
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
46
79
6.10
25.96
1.4
1.9
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
28
27
10.69
25.46
1.5
1.3
%
1.7
2.0
0.15
20
21
(3036525) Urea [Moles/time] in 24 hour Urine
29
5
59.97
25.14
3.1
3.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
66
161
4.36
25.01
1.6
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
42
71
6.17
24.07
1.6
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
29
32
9.35
23.96
2.8
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
66
168
4.18
23.65
1.3
1.2
titre
93.3
61.3
—
9
8
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
86
264
3.52
23.60
1.4
2.0
u/l
40.1
38.9
0.18
73
237
(3035880) pH of Pleural fluid
32
41
8.08
23.54
1.4
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
27
29
9.59
22.74
1.9
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
155
682
2.56
22.32
12.6
9.6
g/l
102.6
122.4
26.94
149
659
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
103
4.99
22.24
3.1
3.1
%
59.1
58.9
0.03
49
103
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
27
30
9.27
22.18
1.9
1.6
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
18
10
18.37
22.15
1.7
1.9
%
16.0
3.4
—
7
5
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
104
373
3.04
22.10
15.0
13.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
150
4.23
22.00
12.3
1.6
nmol/l
1.3
0.8
1.09
45
121
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
120
469
2.82
21.82
2.2
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
30
40
7.74
21.33
5.4
3.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
26
7
38.27
20.87
3.1
1.7
ng/l
164.2
117.9
—
26
7
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
150
673
2.50
20.63
2.5
2.4
ug/l
9.8
7.3
0.43
135
588
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
101
373
2.94
20.34
11.6
11.9
mmol/l
22.6
24.6
7.53
95
351
(40768797) Stomach Pathology biopsy report
173
836
2.35
20.15
1.3
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
68
201
3.59
19.71
1.7
2.8
g/l
0.0
0.0
0.50
60
187
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
39
75
5.41
19.54
1.5
1.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
550
4095
2.00
19.52
6.9
3.1
u/l
75.6
52.1
4.27
523
3770
(3033799) Differential panel - Peritoneal fluid
19
15
12.94
19.48
3.7
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
72
223
3.44
19.44
1.8
2.8
g/l
0.3
1.1
1.54
63
198
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
61
170
3.79
19.27
2.2
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
28
39
7.39
19.17
2.2
2.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
28
39
7.39
19.17
2.3
2.0
%
10.3
10.8
—
10
25
(3019060) Gas panel - Arterial blood
119
494
2.64
19.16
7.6
5.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
19
16
12.13
18.74
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
61
5.77
18.33
1.7
1.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
45
104
4.52
18.23
1.9
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
368
2435
1.91
18.15
11.0
3.9
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
113
471
2.62
18.00
11.7
7.7
mmol/l
22.6
24.6
4.67
103
443
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
48
119
4.22
17.78
1.5
1.3
miu/ml
115.2
264.1
1.61
13
56
(3013707) Erythrocyte sedimentation rate by Westergren method
611
4792
2.02
17.78
8.7
4.0
mm/h
32.6
12.4
58.00
565
4389
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
17
0
+∞
17.77
3.2
0.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
48
120
4.18
17.59
1.6
1.3
mmol/l
56.4
62.8
0.52
36
100
(3000494) Fungus identified in Specimen by Culture
158
778
2.27
17.42
1.7
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
18
16
11.47
17.14
1.2
1.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
18
17
10.80
16.48
22.2
8.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
43
104
4.30
16.45
1.8
1.5
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
21
7
30.72
16.17
1.2
1.0
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
60
186
3.40
16.16
1.7
2.8
g/l
0.0
0.0
0.00
52
172
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
89
4.55
16.05
1.2
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
42
102
4.28
15.98
2.5
2.9
e9/l
4.5
4.3
0.18
42
102
(3042631) Mycobacterium sp identified in Specimen
42
102
4.28
15.98
2.5
2.8
—
—
—
0
0
(44790047)
38
86
4.58
15.79
1.6
1.7
—
—
—
0
0
(44790049)
38
86
4.58
15.79
1.6
1.7
—
—
—
0
0
(44806118)
38
86
4.58
15.79
1.6
1.7
—
—
—
0
0
(44790048)
38
86
4.58
15.79
1.6
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
86
333
2.76
15.79
2.9
2.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
17
16
10.82
15.58
22.4
8.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
135
654
2.27
15.36
6.6
3.5
ng/l
447.1
199.6
4.69
127
598
(21494814) CD8 cells/100 lymphocytes in Specimen
16
14
11.63
15.35
1.4
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
63
209
3.18
15.21
1.9
2.6
g/l
35.5
37.4
1.58
54
177
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
58
183
3.33
15.19
1.7
2.8
g/l
0.0
0.0
0.00
51
171
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
15
12
12.71
15.17
1.1
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
258
1594
1.89
15.12
13.7
6.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
207
3.15
14.81
6.8
3.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
48
138
3.63
14.49
1.4
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
22
32
7.03
14.47
1.2
1.3
nmol/l
1.5
0.9
0.85
15
20
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
13
11.73
14.45
1.5
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
129
629
2.24
14.41
6.1
2.5
u/l
112.5
108.8
0.01
111
537
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
213
1256
1.93
14.26
1.5
1.3
u/ml
3.1
1.4
0.37
45
325
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
18
21
8.74
14.17
1.1
1.2
ug/l
8.8
38.7
—
10
11
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
744
6457
2.36
14.16
71.0
14.9
mg/l
25.9
26.3
0.16
725
5198
(3022217) INR in Platelet poor plasma by Coagulation assay
177
982
2.02
14.12
28.3
28.2
inr
1.5
1.4
0.60
37
130
(21494815) CD4 cells/100 lymphocytes in Specimen
27
51
5.44
13.79
1.4
2.1
%
49.4
36.9
—
5
7
(3001186) Copper [Moles/volume] in Serum or Plasma
14
12
11.85
13.55
1.3
1.1
umol/l
15.2
15.5
0.08
14
12
(3014891) Appearance of Pleural fluid
14
12
11.85
13.55
1.2
1.8
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
17
5
34.65
13.54
6.2
5.2
umol/l
367.4
384.8
—
17
5
(3048689) Calprotectin [Mass/mass] in Stool
135
687
2.15
13.52
2.3
2.4
ug/g
194.8
124.9
1.26
109
557
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
76
4.48
13.43
2.3
2.1
u/l
3507.6
1126.6
0.29
19
24
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
91
4.09
13.01
1.2
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
28
58
4.96
12.92
1.5
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
18
9.04
12.92
2.5
1.8
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
17
21
8.24
12.79
2.4
2.2
e6/l
3841.2
2885.9
—
9
13
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
22
37
6.08
12.64
1.6
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
22
37
6.08
12.64
1.6
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
22
37
6.08
12.64
1.6
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
22
37
6.08
12.64
1.6
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
73
294
2.62
12.39
3.4
3.2
pmol/l
3.8
4.5
6.26
65
258
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
55
191
3.01
12.30
3.8
2.3
ug/min
713.1
101.9
2.52
33
114
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
49
159
3.21
12.28
1.4
2.0
mg/l
16.8
12.3
1.19
43
143
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
32
6.38
12.05
1.2
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
26
54
4.94
11.97
1.1
1.2
—
—
—
0
0
(4281824)
25
51
5.02
11.74
1.9
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
27
6.79
11.50
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
25
52
4.92
11.49
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
13
13
10.14
11.36
2.0
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
65
4.42
11.30
2.8
2.2
u/field
1.9
2.3
0.13
11
25
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
68
278
2.57
11.20
2.6
3.8
u/ml
137.6
14134.4
0.80
61
238
(3024980) IgG subclass 4 [Mass/volume] in Serum
35
97
3.72
11.17
1.5
1.7
g/l
0.5
0.7
0.66
27
76
(3032057) Clostridioides difficile [Presence] in Stool
14
16
8.88
11.14
2.6
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
21
39
5.50
10.92
1.1
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
21
39
5.50
10.92
1.1
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
7
448
0.15
10.88
1.0
1.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
33
90
3.78
10.77
1.1
1.1
g/l
1.8
1.5
2.14
28
84
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
17
27
6.41
10.30
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
17
27
6.41
10.30
1.1
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
38
5.37
10.15
3.4
2.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
31
5.91
10.10
1.4
1.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
28
73
3.93
9.74
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
26
65
4.10
9.56
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
26
65
4.10
9.56
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
26
65
4.10
9.56
1.5
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
33
5.55
9.48
1.2
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
17
30
5.76
9.30
1.4
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
30
5.76
9.30
1.2
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
17
30
5.76
9.30
1.4
1.9
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
63
272
2.42
9.26
5.7
3.9
mmol/l
1.4
1.4
0.08
52
266
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
209
1376
1.69
9.21
6.1
4.0
ng/l
1295.6
309.3
1.12
186
1145
(3024139) IgG subclass 3 [Mass/volume] in Serum
23
54
4.35
9.17
1.4
1.2
g/l
0.5
0.4
0.28
18
39
(3049717) Cytology report of Urine Cyto stain
72
333
2.27
9.06
2.5
2.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
17
31
5.58
9.00
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
103
550
2.00
8.95
12.5
3.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
34
108
3.24
8.86
1.1
1.1
—
—
—
0
0
(4062490)
23
56
4.19
8.76
1.4
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
19
40
4.84
8.62
1.3
2.1
umol/l
6.4
9.4
0.31
14
27
(3029937) Albumin [Presence] in Urine by Test strip
251
1758
1.61
8.59
9.4
3.9
estimate
0.0
0.0
0.69
94
565
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
22
53
4.24
8.50
1.1
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
11
13
8.56
8.48
1.4
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
13
19
6.93
8.46
1.3
1.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
745
6747
1.94
8.41
84.4
17.9
mmol/l
138.7
139.7
17.92
738
6567
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
27
77
3.59
8.30
1.3
1.5
%
76.0
61.9
1.21
15
53
(3051651) Icteric interference index of Serum or Plasma
19
42
4.61
8.15
10.7
3.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
745
6768
1.91
8.02
87.5
18.0
mmol/l
4.2
4.0
47.05
739
6578
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
45
178
2.61
7.95
2.6
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
31
5.24
7.95
1.6
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
44
173
2.63
7.87
1.7
1.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
28
5.44
7.75
1.1
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
12
8.42
7.59
1.1
1.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
12
8.42
7.59
1.1
1.1
%
94.1
78.3
—
10
12
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
83
3.33
7.43
1.4
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
33
4.92
7.43
1.4
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
33
4.92
7.43
1.4
1.7
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
12
9
13.50
7.40
1.7
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
59
274
2.24
7.37
2.8
1.9
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
21
55
3.89
7.29
1.3
2.2
e6/l
521.8
766.3
0.80
13
18
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
138
861
1.72
7.28
9.7
4.6
%
33.7
32.0
1.03
132
559
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
14
27
5.26
6.99
3.3
2.8
u/l
207.0
214.3
0.13
14
27
(3004451) EKG impression Narrative
17
39
4.43
6.98
1.6
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
48
4.03
6.92
1.5
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
20
6.07
6.92
1.6
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
33
121
2.80
6.77
1.4
1.2
—
2.1
—
0
10
(3006270) Folate [Moles/volume] in Blood
22
63
3.56
6.75
1.1
1.1
nmol/l
386.4
359.1
0.19
14
54
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
39
158
2.54
6.60
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
39
158
2.54
6.60
1.8
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
21
5.78
6.60
3.3
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
22
65
3.45
6.45
1.6
1.4
—
—
—
0
0
(3025315) Body weight
10
7
14.44
6.41
5.0
3.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
435
0.22
6.38
1.7
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
325
2534
1.46
6.38
2.6
2.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
642
5709
1.53
6.29
58.1
16.4
%
30.5
39.7
53.31
384
3877
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
14
30
4.73
6.23
2.3
1.9
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
19
5.85
6.12
1.1
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
18
48
3.81
6.11
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
36
146
2.53
6.10
1.3
1.2
u/ml
9.6
13.7
—
5
22
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
28
100
2.86
6.04
1.2
1.1
iu/ml
68.0
35.6
—
5
21
(3021788) Differential panel - Synovial fluid
32
123
2.67
6.03
1.6
1.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
64
3.34
5.89
1.2
1.2
pmol/l
313.8
305.3
0.03
14
51
(3022145) Colonoscopy Study observation
114
717
1.68
5.80
1.3
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
75
3.12
5.80
3.0
4.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
76
426
1.86
5.73
5.4
3.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
38
164
2.38
5.66
1.5
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
18
51
3.58
5.63
1.2
1.2
—
70.4
—
0
7
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
20
61
3.33
5.61
1.2
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
14
33
4.30
5.57
1.4
1.2
u/l
32.1
14.1
1.26
14
27
(3017569) Oxygen content in Arterial blood
16
42
3.86
5.56
1.6
3.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
73
3.07
5.40
1.1
1.3
nmol/l
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
14
34
4.17
5.37
1.4
1.2
u/l
108.1
92.9
0.15
14
29
(3044290) Cell count panel - Cerebral spinal fluid
29
113
2.62
5.35
1.2
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
20
63
3.23
5.34
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
76
437
1.81
5.29
1.2
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
31
126
2.52
5.26
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
59
3.27
5.19
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
75
2.99
5.17
1.1
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
22
75
2.99
5.17
1.6
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
666
6051
1.49
5.11
58.4
14.0
ml/min/173m2
40.6
77.2
127.83
619
5016
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
738
6858
1.64
5.10
32.9
10.4
u/l
21.7
26.8
14.71
726
6588
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
664
6031
1.49
5.08
14.0
6.2
mmol/mol
44.5
40.5
10.08
642
5527
(3014271) Vancomycin [Susceptibility]
17
50
3.45
5.05
3.2
2.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
25
93
2.74
5.04
1.4
1.2
u/ml
2.4
5.1
—
10
46
(4306422)
23
82
2.86
5.01
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
424
3571
1.38
4.99
3.5
2.7
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
16
47
3.45
4.76
1.8
2.9
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
20
68
2.99
4.74
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
589
5258
1.40
4.74
78.8
18.3
%
15.1
13.7
59.63
582
5156
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
5
14.10
4.58
1.1
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
21
4.81
4.54
1.1
1.2
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
18
59
3.10
4.54
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
19
65
2.97
4.46
10.9
3.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
41
203
2.07
4.45
2.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
530
4675
1.36
4.41
5.0
3.6
pmol/l
14.7
14.9
1.25
487
4175
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
9
12
7.57
4.36
15.4
10.0
—
—
—
0
0
(44806071)
7
6
11.75
4.28
1.1
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
68
407
1.73
4.17
6.7
2.5
e9/l
4.5
4.1
0.49
48
306
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
10
23
4.39
4.09
1.4
1.5
ug/l
71.8
57.9
—
10
23
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
10
8.06
4.06
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
10
8.06
4.06
1.1
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
42
3.37
4.05
1.5
1.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
196
1494
1.41
4.05
5.6
3.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
7
7
10.07
4.01
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
18
65
2.81
3.87
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
11
7.33
3.86
1.1
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
60
2.87
3.81
1.2
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
55
2.95
3.75
1.3
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
16
5.67
3.66
1.6
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
9
16
5.67
3.66
2.8
3.2
u/l
9731.3
5228.1
—
9
16
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
9
7.83
3.56
3.1
3.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
9
7.83
3.56
1.1
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
32
159
2.05
3.49
5.5
3.7
mg/l
52.3
28.0
1.46
22
107
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
18
5.04
3.37
2.3
3.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
26
121
2.19
3.35
1.4
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
77
2.50
3.31
3.8
2.5
mg/l
25.7
25.3
—
7
19
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
48
2.95
3.31
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
35
184
1.94
3.29
1.6
1.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
7
8.62
3.26
1.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
28
3.60
3.20
4.2
4.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
44
2.99
3.14
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
73
2.50
3.14
1.0
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
34
3.27
3.06
1.5
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
8
7.54
3.06
1.5
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
15
57
2.66
2.97
1.5
1.3
%
21.2
24.7
—
9
38
(3043409) Potassium [Moles/volume] in Arterial blood
40
229
1.78
2.92
7.9
4.0
mmol/l
4.4
4.0
3.12
29
211
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
10
30
3.36
2.91
1.8
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
30
3.36
2.91
1.1
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
28
144
1.98
2.83
1.6
1.4
u/l
16.5
8.1
1.07
20
110
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
13
47
2.79
2.82
3.5
3.3
%
41.7
39.7
—
7
13
(3001019) Free T4 and TSH panel - Serum or Plasma
6
191
0.31
2.82
3.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
23
3.94
2.78
1.3
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
6
8.37
2.75
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
6
8.37
2.75
1.2
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
14
5.03
2.73
1.3
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
10
6.03
2.70
2.3
2.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
10
6.03
2.70
1.2
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
141
1.95
2.63
1.2
1.4
e6/l
16.0
72.4
0.74
21
114
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
141
1.95
2.63
1.4
1.5
e6/l
1188.1
913.4
0.09
21
117
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
19
87
2.21
2.59
1.5
1.2
u/ml
2.0
1.5
—
10
29
(3019174) dRVVT (LA screen)
5
7
7.18
2.55
1.6
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
6
11
5.49
2.54
1.5
1.4
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
11
5.49
2.54
2.3
2.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
14
56
2.53
2.54
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
707
6706
1.35
2.53
74.0
14.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
746
7137
1.41
2.53
98.6
21.8
e9/l
235.4
240.5
0.98
739
6937
(3024731) MCV [Entitic volume]
746
7137
1.41
2.53
98.4
21.7
fl
93.1
91.4
16.44
741
7014
(3035941) MCH [Entitic mass]
746
7138
1.41
2.52
98.3
21.7
pg
30.3
30.4
1.25
741
7015
(3026361) Erythrocytes [#/volume] in Blood
746
7139
1.41
2.50
98.7
21.8
e12/l
3.6
4.5
245.29
737
6915
(3010813) Leukocytes [#/volume] in Blood
746
7141
1.41
2.48
99.1
21.8
e9/l
7.3
6.8
2.63
740
6916
(3000963) Hemoglobin [Mass/volume] in Blood
746
7141
1.41
2.48
99.6
21.9
g/l
108.5
136.1
296.77
739
7015
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.40
2.48
1.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
16
4.40
2.48
1.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
12
5.03
2.40
1.2
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
15
64
2.37
2.40
1.4
1.4
e6/l
18095.1
180505.1
—
9
45
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
646
6067
1.28
2.39
7.6
4.1
mmol/l
1.4
1.3
5.26
613
5485
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
8
6.28
2.37
1.2
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
8
6.28
2.37
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
22
3.66
2.37
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
22
3.66
2.37
1.1
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
619
5788
1.27
2.34
6.1
4.4
mu/l
2.3
2.0
5.64
594
5182
(3032773) Endomysium IgG Ab [Titer] in Serum
13
53
2.48
2.28
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
99
2.05
2.27
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
348
3070
1.23
2.24
4.8
5.2
ug/l
10.5
3.1
2.57
318
2727
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
9
5.58
2.21
1.8
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
30
3.02
2.15
1.1
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
16
75
2.16
2.09
2.0
2.8
nmol/l
13.3
3.7
1.19
16
75
(3020891) Body temperature
44
287
1.56
2.04
5.3
4.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
28
162
1.75
2.04
1.6
1.6
e6/l
22477.7
18303.1
0.20
20
111
(4198724)
7
21
3.35
1.97
2.6
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
21
3.35
1.97
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
21
3.35
1.97
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
21
3.35
1.97
1.3
2.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
8
27
2.98
1.94
1.1
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
148
1798
0.79
1.93
2.8
3.1
ug/l
1.2
0.8
2.24
122
1219
(3039162) Centromere protein B Ab [Units/volume] in Serum
15
71
2.13
1.93
1.5
1.2
—
74.5
—
0
5
(4010399)
30
479
0.61
1.91
1.3
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
51
0.00
1.89
0.0
1.1
—
5.2
—
0
22
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
22
3.20
1.88
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
10
223
0.44
1.86
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
59
2.22
1.85
1.2
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
109
857
1.31
1.84
1.5
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
161
1331
1.26
1.84
4.3
3.1
mmol/l
2.5
2.5
1.11
143
1161
(3006653) Thiamine [Moles/volume] in Blood
10
40
2.52
1.84
1.5
1.2
nmol/l
164.8
137.9
—
10
40
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
12
4.18
1.82
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
35
2.59
1.80
31.8
15.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
23
3.06
1.80
1.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
23
3.06
1.80
1.1
1.0
iu/ml
618.1
144.3
—
7
23
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
65
875
0.72
1.77
11.8
7.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
154
0.39
1.77
2.0
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
24
2.93
1.72
3.9
3.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
14
3.59
1.61
1.2
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
14
3.59
1.61
1.0
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
27
168
1.63
1.57
2.3
3.1
nmol/l
1.2
0.9
0.44
12
135
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
29
443
0.64
1.56
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
219
2500
0.83
1.56
4.4
4.5
%
27.0
21.6
4.18
124
1257
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
15
3.35
1.52
1.6
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
29
186
1.58
1.50
1.3
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
38
2.38
1.46
2.9
1.4
g/l
1.0
1.0
—
9
38
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
188
1.56
1.44
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
16
3.14
1.44
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
421
0.65
1.42
1.4
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
190
1.55
1.39
1.3
1.2
—
—
—
0
0
(4268621)
13
67
1.96
1.39
1.8
2.2
—
—
—
0
0
(4015189)
6
24
2.51
1.30
2.3
2.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
235
2088
1.17
1.29
6.1
3.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
25
2.41
1.24
3.5
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
25
2.41
1.24
3.5
2.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
26
382
0.67
1.21
1.4
1.8
—
—
—
0
0
(3000492) Spirometry study
44
587
0.74
1.19
1.4
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
166
1442
1.19
1.19
6.7
4.2
kg/l
1.0
1.0
5.30
43
197
(44806420)
6
26
2.32
1.19
3.3
2.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
38
2.12
1.18
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
23
149
1.56
1.18
1.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
185
0.53
1.16
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
657
6332
1.17
1.13
8.1
4.6
mmol/l
4.1
4.5
22.20
621
5795
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
138
0.50
1.10
1.9
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
41
1.96
1.09
2.1
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
17
105
1.63
1.06
1.4
1.4
—
—
—
0
0
(4027681)
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
492
4667
1.13
1.00
6.1
4.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
337
1.32
0.97
1.1
1.2
iu/ml
205.9
128.8
0.54
13
134
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
278
1.35
0.93
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
38
289
1.33
0.89
1.2
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
29
2.08
0.89
1.3
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
29
2.08
0.89
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
21
145
1.46
0.85
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
649
6292
1.14
0.85
8.1
4.5
mmol/l
1.3
1.4
8.14
615
5722
(3023511) Choriogonadotropin [Units/volume] in Urine
8
45
1.79
0.84
1.8
1.0
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.2
—
4.5
—
0
13
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
183
1.38
0.76
2.0
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
108
1.49
0.74
1.6
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
106
0.56
0.73
1.5
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
4.0
1.3
ug/l
1.9
3.9
—
5
22
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
189
1735
1.12
0.65
2.2
1.6
mmol/l
1.5
1.4
1.41
171
1448
(4094501)
11
165
0.66
0.63
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
101
0.59
0.62
1.3
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
0.4
—
0
7
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
21
0.00
0.60
0.0
1.1
—
254.2
—
0
13
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
14
98
1.44
0.56
1.8
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
10
65
1.54
0.55
1.7
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
60
1.51
0.54
1.2
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
75
1.47
0.51
1.1
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
661
6477
1.10
0.50
8.1
5.1
mmol/l
2.2
2.7
35.26
627
5889
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
107
969
1.12
0.49
1.2
1.3
iu/ml
97.8
39.0
1.34
28
289
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
13
175
0.74
0.45
1.6
1.9
—
—
—
0
0
(4146454)
12
87
1.38
0.42
3.3
2.6
—
—
—
0
0
(4133840)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
3.3
—
0
9
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
18
0.00
0.40
0.0
1.6
—
7.5
—
0
12
(3017446) Testosterone [Moles/volume] in Serum or Plasma
66
590
1.13
0.39
2.0
2.2
nmol/l
8.9
13.1
3.44
55
520
(37021550) Renin [Units/volume] in Plasma --upright
0
19
0.00
0.39
0.0
1.3
—
56.4
—
0
14
(3002619) Bacteria identified in Specimen by Culture
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
36
1.39
0.38
2.2
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
42
1.43
0.35
1.7
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
101
1.29
0.32
1.8
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
588
0.89
0.30
1.6
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
67
1.20
0.26
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
82
880
0.92
0.25
1.3
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
15.6
—
0
10
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
6.3
—
0
10
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
98
932
1.06
0.18
1.2
1.2
u/ml
26.3
11.5
0.61
34
339
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
73
689
1.07
0.17
1.8
1.8
%
1.9
1.5
3.05
50
589
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
83
1.09
0.14
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
150
1.14
0.14
1.3
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
97
0.82
0.13
2.0
1.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
11
94
1.17
0.13
4.8
4.1
umol/l
308.5
360.2
0.65
11
81
(40768793) Breast Pathology biopsy report
10
115
0.87
0.10
1.2
1.3
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
13
146
0.89
0.10
2.0
1.9
pmol/l
179.5
220.0
0.77
13
135
(3027008) Opiates [Presence] in Urine
13
146
0.89
0.10
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
145
0.89
0.09
2.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
5
62
0.81
0.08
1.0
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
146
1.10
0.08
5.4
2.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
63
652
0.96
0.08
1.2
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
284
1.06
0.07
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
39
380
1.03
0.03
1.1
1.3
—
43.3
—
0
19
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
628
6293
0.99
0.02
9.5
4.8
mmol/l
6.8
6.1
10.16
591
5664
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
363
1.02
0.01
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
42
427
0.98
0.01
2.2
2.5
—
17.5
—
0
14
(1001926) Buprenorphine [Presence] in Urine by Screen method
11
116
0.95
0.00
2.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
146
0.96
0.00
1.9
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
14
146
0.96
0.00
1.9
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
20
195
1.03
0.00
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
139
1.01
0.00
1.9
1.3
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.1
—
0
5
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
3.6
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
5
53
0.94
0.00
1.0
1.0
ng/l
41.8
39.2
—
5
25
(3005570) Glucose [Moles/volume] in Urine
7
77
0.91
0.00
1.7
1.9
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
5
53
0.94
0.00
1.0
1.0
ng/l
364.2
256.9
—
5
27
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_ANAEMIAINCHRONICDISEASE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ANAEMIAINCHRONICDISEASE | 5.038 [3.9, 6.51] | < 0.001 |
| Birth year | 0.999 [0.99, 1.01] | 0.886 |
During the follow-up period (1.1.1998 — 31.12.2019), 1200 out of 1901 females with D3_ANAEMIAINCHRONICDISEASE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_ANAEMIAINCHRONICDISEASE | 5.365 [3.81, 7.55] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.029 |
During the follow-up period (1.1.1998 — 31.12.2019), 1351 out of 2167 males with D3_ANAEMIAINCHRONICDISEASE died.
Mortality risk
Mortality risk for people of age
years, who have D3_ANAEMIAINCHRONICDISEASE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.614% | 1.111% |
| 5 | 3.131% | 6.608% |
| 10 | 7.479% | 15.419% |
| 15 | 15.405% | 27.787% |
| 20 | 25.086% | 42.426% |
Relationships between endpoints
↥Index endpoint: D3_ANAEMIAINCHRONICDISEASE – Anaemia in chronic diseases classified elsewhere
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data